Healthcare professionals who demonstrated excellence in inpatient diabetes care during the pandemic are being encouraged to enter a national diabetes competition ahead of the deadline next month.
This year’s Rowan Hillson Inpatient Safety Award will acknowledge and applaud an individual who has ‘redesigned, rebuilt and maintained safe inpatient diabetes care during COVID-19’, after the award was postponed last year due the pandemic.
The winning application will showcase evidence of simple and cost-efficient improvements that can easily be adopted in other Trusts, with the judging panel also looking for projects which have been commissioned or supported by an Acute Trust.
Organised by Consultant Endocrinologist and Diabetologist Dr Umesh Dashora and Diabetes Nurse Consultant Erwin Castro, the annual JBDS – IP competition accepts entries from all healthcare professionals working in the UK.
Dr Dashora said: “Over the years Rowan Hillson Awards have discovered many excellent innovations and practices throughout the country.
“I am sure this award will identify excellent novel approaches for maintaining safe in-patient diabetes care during COVID times.”
An impartial judging panel chaired by Rowan Hillson will assess each application against an established criteria before the ABCD Spring meeting 2022 where the winner will be revealed.
Additionally, details of the successful project will be made available on the websites of Diabetes UK, DISN UK and the ABCD.
Healthcare professionals have until Monday, February 28 to enter the competition. Please note this competition is only for projects undertaken during the COVID-19 pandemic.
In 2019, a Newport-based team led by Dr David Burkett-St.Laurent were awarded the accolade for their cross specialty working group which re-designed the perioperative care pathway for surgical patients with diabetes. Significant improvements for staff and people with diabetes were seen because of their work.
To submit an application for this year’s Rowan Hillson Inpatient Safety Award, click here.